
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy Inc. has demonstrated a solid financial performance, highlighted by a sequential commercial pricing increase of 2.2%, indicating consistent demand for its services despite minor regional challenges. Additionally, the company's Industrial Injury Prevention (IIP) revenue showed robust growth, achieving a 22.2% increase overall and an impressive 18.4% growth when excluding contributions from mergers and acquisitions. These metrics reflect the company's strong operational capabilities and market positioning, reinforcing a positive outlook for its future financial performance.
Bears say
US Physical Therapy Inc has experienced a 0.6% decline in key revenue metrics, which fell to $83.95 compared to $84.46 in the previous year, signaling potential instability in revenue generation. The company has faced continuous reimbursement cuts over the past five years, resulting in a total profitability headwind of $20 million, further straining financial performance. Additionally, expenses related to rent, clinic operations, and contract labor have increased to 20.2% of revenue, slightly exceeding previous estimates, indicating rising operational costs that may hinder profitability.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares